SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-13-356406
Filing Date
2013-09-04
Accepted
2013-09-04 10:42:33
Documents
3
Group Members
KING VIEW DEVELOPMENT INTERNATIONAL LTDTB PARTNERS GP2, L.P.TRUSTBRIDGE PARTNERS II, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d593377dsc13d.htm SC 13D 119869
2 EX-7.01 d593377dex701.htm EX-7.01 6032
3 EX-7.04 d593377dex704.htm EX-7.04 42692
  Complete submission text file 0001193125-13-356406.txt   170343
Mailing Address NO. 699-18 XUAN WU AVENUE XUAN WU DISTRICT NANJING, JIANGSU PROVINCE F4 210042
Business Address NO. 699-18 XUAN WU AVENUE XUAN WU DISTRICT NANJING, JIANGSU PROVINCE F4 210042 (86)-25-8556-6666
Simcere Pharmaceutical Group (Subject) CIK: 0001384360 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83690 | Film No.: 131076960
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2701B, AZIA CENTER 1233 LUJIAZUI RING ROAD SHANGHAI F4 200120
Business Address 2701B, AZIA CENTER 1233 LUJIAZUI RING ROAD SHANGHAI F4 200120 8621-5877-5990
TB Partners GP LTD (Filed by) CIK: 0001436081 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D